Wiley Matthew T. Insider Trades

Insider Trading History

Track insider trading activity for Wiley Matthew T.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Definium Therapeutics
Definium Therapeutics DFTX
Chief Commercial Officer
Holding Value $2.83M 115,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$24.59
Definium Therapeutics
Definium Therapeutics DFTX
Chief Commercial Officer
Holding Value $8.61M 350,000 shares
Last Trade
Mar 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$24.59
Mind Medicine
Mind Medicine MNMD
Chief Commercial Officer
Holding Value $7.24M 350,000 shares
Last Trade
Mar 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 350,000 shares
$6.35
$20.69
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Commercial Officer
Holding Value $23.4k 19,011 shares
Last Trade
Oct 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$55.2k 6,272 shares
$8.80
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Commercial Officer
Holding Value $31.1k 25,283 shares
Last Trade
Sep 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$214k 21,250 shares
$10.09
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Commercial Officer
Holding Value $4.96k 4,033 shares
Last Trade
Sep 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.2k 215 shares
$10.24
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Commercial Officer
Holding Value $9.23k 7,500 shares
Last Trade
Sep 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.16k 750 shares
$10.88
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Commercial Officer
Holding Value $5.23k 4,248 shares
Last Trade
Sep 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.16k 750 shares
$10.88
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
other, See Remarks
Holding Value $2.31k 1,875 shares
Last Trade
Jul 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36k 1,875 shares
$19.20
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Commercial Officer
Holding Value $10.1k 8,250 shares
Last Trade
Jun 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.4k 750 shares
$21.92
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Commercial Officer
Holding Value $10.1k 8,250 shares
Last Trade
Jun 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.4k 750 shares
$21.92
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
CHIEF COMMERCIAL OFFICER
Holding Value $11.1k 9,000 shares
Last Trade
Mar 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$129k 3,000 shares
$42.88
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
CHIEF COMMERCIAL OFFICER
Holding Value $44.3k 36,000 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.1M 48,000 shares
$313.60
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
CHIEF COMMERCIAL OFFICER
Holding Value $105k 85,000 shares
Last Trade
Jan 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.5M 85,000 shares
$312.00
$1.23
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Commercial Officer
Holding Value $72.7k 109,246 shares
Last Trade
Jun 30, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.1k 5,151 shares
$3.51
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Commercial Officer
Holding Value $76.1k 114,397 shares
Last Trade
Mar 31, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.6k 2,573 shares
$6.84
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Commercial Officer
Holding Value $77.8k 116,970 shares
Last Trade
Feb 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$538k 64,575 shares
$8.33
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Commercial Officer
Holding Value $238k 357,181 shares
Last Trade
Dec 31, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.43k 1,541 shares
$1.58
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Commercial Officer
Holding Value $239k 358,722 shares
Last Trade
Nov 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.3k 7,838 shares
$1.70
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Commercial Officer
Holding Value $233k 350,884 shares
Last Trade
Sep 30, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.56k 1,541 shares
$1.66
$0.67

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up